Estimating the effective density of engineered nanomaterials for in vitro dosimetry

The need for accurate in vitro dosimetry remains a major obstacle to the development of cost-effective toxicological screening methods for engineered nanomaterials. An important key to accurate in vitro dosimetry is the characterization of sedimentation and diffusion rates of nanoparticles suspended in culture media, which largely depend upon the effective density and diameter of formed agglomerates in suspension. Here we present a rapid and inexpensive method for accurately measuring the effective density of nano-agglomerates in suspension. This novel method is based on the volume of the pellet obtained by bench-top centrifugation of nanomaterial suspensions in a packed cell volume tube, and is validated against gold-standard analytical ultracentrifugation data. This simple and cost-effective method allows nanotoxicologists to correctly model nanoparticle transport, and thus attain accurate dosimetry in cell culture systems, which will greatly advance the development of reliable and efficient methods for toxicological testing and investigation of nano-bio interactions in vitro.

[1]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[2]  Pratim Biswas,et al.  Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data. , 2012, Toxicology.

[3]  Joel G Pounds,et al.  ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies , 2010, Particle and Fibre Toxicology.

[4]  K. Wittmaack.  Novel dose metric for apparent cytotoxicity effects generated by in vitro cell exposure to silica nanoparticles. , 2011, Chemical research in toxicology.

[5]  H. Makse,et al.  A phase diagram for jammed matter , 2008, Nature.

[6]  W. Knoll,et al.  Surface modification of citrate-reduced colloidal gold nanoparticles with 2-mercaptosuccinic acid , 2003 .

[7]  G. Sotiriou,et al.  A novel platform for pulmonary and cardiovascular toxicological characterization of inhaled engineered nanomaterials , 2012, Nanotoxicology.

[8]  P. Schuck,et al.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. , 2000, Biophysical journal.

[9]  D. Dix,et al.  Informing Selection of Nanomaterial Concentrations for ToxCast in Vitro Testing Based on Occupational Exposure Potential , 2011, Environmental health perspectives.

[10]  Joel M. Cohen,et al.  Effects of copy center particles on the lungs: a toxicological characterization using a Balb/c mouse model , 2013, Inhalation toxicology.

[11]  S. Pratsinis,et al.  Development and characterization of a Versatile Engineered Nanomaterial Generation System (VENGES) suitable for toxicological studies , 2010, Inhalation toxicology.

[12]  Alison Elder,et al.  Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. , 2010, ACS nano.

[13]  Joel G Pounds,et al.  Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  John T Elliott,et al.  Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity , 2011, Nanotoxicology.

[15]  F. Wurm,et al.  New disposable tubes for rapid and precise biomass assessment for suspension cultures of mammalian cells. , 2006, Biotechnology and bioengineering.

[16]  T. Darrah,et al.  Palladium(II) and platinum(II) bind strongly to an engineered blue copper protein. , 2011, Inorganic chemistry.

[17]  P. Biswas,et al.  Concept of Assessing Nanoparticle Hazards Considering Nanoparticle Dosemetric and Chemical/Biological Response Metrics , 2010, Journal of toxicology and environmental health. Part A.

[18]  Mark R. Wiesner,et al.  Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment – issues and recommendations , 2011, Nanotoxicology.

[19]  Wendel Wohlleben,et al.  Validity range of centrifuges for the regulation of nanomaterials: from classification to as-tested coronas , 2012, Journal of Nanoparticle Research.

[20]  Jin Young Kim,et al.  Determination of nanoparticle size distribution together with density or molecular weight by 2D analytical ultracentrifugation , 2011, Nature communications.

[21]  Lutz Mädler,et al.  Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. , 2011, ACS nano.

[22]  Saber M Hussain,et al.  Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  J. Zook,et al.  Measuring agglomerate size distribution and dependence of localized surface plasmon resonance absorbance on gold nanoparticle agglomerate size using analytical ultracentrifugation. , 2011, ACS nano.

[24]  Wei Bai,et al.  Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation , 2010, Nanotechnology.

[25]  R. C. Weast.  CRC Handbook of Chemistry and Physics , 1973 .

[26]  Jeffrey I. Zink,et al.  Dispersion and stability optimization of TiO2 nanoparticles in cell culture media. , 2010, Environmental science & technology.

[27]  Klein,et al.  Universal reaction-limited colloid aggregation. , 1990, Physical review. A, Atomic, molecular, and optical physics.

[28]  M. C. Sterling,et al.  Application of fractal flocculation and vertical transport model to aquatic sol-sediment systems. , 2005, Water research.

[29]  Younan Xia,et al.  The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. , 2011, Nature nanotechnology.

[30]  David Y Lai,et al.  Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[31]  Steven K. Gibb.  Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.

[32]  Amanda Hayes,et al.  Nanoparticles: a review of particle toxicology following inhalation exposure , 2012, Inhalation toxicology.

[33]  P. Hauschka,et al.  Incorporation of excess gadolinium into human bone from medical contrast agents. , 2009, Metallomics : integrated biometal science.

[34]  Robert N Grass,et al.  Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. , 2005, Environmental science & technology.

[35]  Lutz Mädler,et al.  Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. , 2012, ACS nano.

[36]  Philip Demokritou,et al.  Interactions of engineered nanomaterials in physiological media and implications for in vitro dosimetry , 2013, Nanotoxicology.

[37]  Sotiris E. Pratsinis,et al.  Scale-up of nanoparticle synthesis in diffusion flame reactors , 2003 .

[38]  Philip Demokritou,et al.  A Safer Formulation Concept for Flame-Generated Engineered Nanomaterials. , 2012, ACS sustainable chemistry & engineering.

[39]  Anoop K. Pal,et al.  Evaluation of cytotoxic, genotoxic and inflammatory responses of nanoparticles from photocopiers in three human cell lines , 2013, Particle and Fibre Toxicology.

[40]  G. Oberdörster,et al.  Nanotoxicology: in Vitro–in Vivo Dosimetry , 2012, Environmental health perspectives.

[41]  Philip Demokritou,et al.  An in vivo and in vitro toxicological characterisation of realistic nanoscale CeO2 inhalation exposures , 2013, Nanotoxicology.

[42]  W. M. Haynes.  CRC Handbook of Chemistry and Physics , 1990 .

[43]  B. Forbes,et al.  The delivered dose: Applying particokinetics to in vitro investigations of nanoparticle internalization by macrophages. , 2012, Journal of controlled release : official journal of the Controlled Release Society.